Profile
Lynne E.
Weissberger has been Vice President of Regulatory Affairs and Quality Assurance for ImaRx Therapeutics, Inc. since February, 2006.
Prior to that, she was Senior Director of Myogen, Inc. from January, 2004 to December, 2005.
Previously, she was an Associate Director for GD Searle, Pharmacia, Inc. and Pfizer from April, 1996 to December, 2003.
Dr. Weissberger received a PhD in Nutrition and Physiology from Cornell University.
Former positions of Lynne E. Weissberger
| Companies | Position | End |
|---|---|---|
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Director/Board Member | 30/11/2005 |
| Pharmacia, Inc. | Director/Board Member | 30/11/2003 |
| PFIZER, INC. | Director/Board Member | 30/11/2003 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | General Counsel | - |
Training of Lynne E. Weissberger
| Cornell University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 3 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
| Pharmacia, Inc. |
- Stock Market
- Insiders
- Lynne E. Weissberger
